Hisham Shady Nourhan, Youssif Khayrya A, Sayed Ahmed M, Belbahri Lassaad, Oszako Tomasz, Hassan Hossam M, Abdelmohsen Usama Ramadan
Department of Pharmacognosy, Faculty of Pharmacy, Deraya University, Universities Zone, P.O. Box 61111, New Minia City, Minia 61519, Egypt.
Department of Pharmacognosy, Faculty of Pharmacy, Modern University for Technology and Information, Cairo 11865, Egypt.
Plants (Basel). 2020 Dec 26;10(1):41. doi: 10.3390/plants10010041.
The acute respiratory syndrome caused by the novel coronavirus (SARS-CoV-2) caused severe panic all over the world. The coronavirus (COVID-19) outbreak has already brought massive human suffering and major economic disruption and unfortunately, there is no specific treatment for COVID-19 so far. Herbal medicines and purified natural products can provide a rich resource for novel antiviral drugs. Therefore, in this review, we focused on the sterols and triterpenes as potential candidates derived from natural sources with well-reported in vitro efficacy against numerous types of viruses. Moreover, we compiled from these reviewed compounds a library of 162 sterols and triterpenes that was subjected to a computer-aided virtual screening against the active sites of the recently reported SARS-CoV-2 protein targets. Interestingly, the results suggested some compounds as potential drug candidates for the development of anti-SARS-CoV-2 therapeutics.
新型冠状病毒(SARS-CoV-2)引起的急性呼吸综合征在全球范围内引发了严重恐慌。冠状病毒(COVID-19)的爆发已经给人类带来了巨大痛苦和重大经济破坏,不幸的是,目前尚无针对COVID-19的特效治疗方法。草药和纯化的天然产物可为新型抗病毒药物提供丰富资源。因此,在本综述中,我们重点关注了甾醇和三萜类化合物,它们是天然来源的潜在候选物,已有充分报道显示其对多种病毒具有体外抗病毒活性。此外,我们从这些经过综述的化合物中整理出了一个包含162种甾醇和三萜类化合物的库,并对其进行了针对最近报道的SARS-CoV-2蛋白靶点活性位点的计算机辅助虚拟筛选。有趣的是,结果表明某些化合物有望成为开发抗SARS-CoV-2治疗药物的候选药物。